BACKGROUND Approximately 8% of HIV-infected individuals are co-infected with hepatitis B virus (HBV) in sub-Saharan Africa (SSA). Knowledge of HBV status is important to guide optimal selection of antiretroviral therapy (ART) and monitor/prevent liver-related complications. We describe changes in testing practices and management of HBV infection over a 3-year period in HIV clinics across SSA. METHODS A medical chart review was conducted in large urban HIV treatment centers in Côte d'Ivoire (3 sites), Benin, Burkina Faso, Cameroon, Kenya, Senegal, South Africa, Togo, Uganda and Zambia (1 site each). Of the patients who started ART between 2010 and 2012, 100 per year were randomly selected from each clinic. Demographic, clinical and ...
Background: Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) co-infection in South Afr...
BACKGROUND In West Africa where HIV-1 and HIV-2 co-circulate, the co-infection with hepatitis B v...
BACKGROUND: International Sustainable Development Goals (SDGs) for elimination of hepatitis B virus ...
Abstract Background Approximately 8% of HIV-infected individuals are co-infected with hepatitis B vi...
Chronic hepatitis B virus (HBV) infection affects >10% of the general population and is the leading ...
Background: Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV ...
\ud \ud Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in S...
BACKGROUND: Few data on the virological determinants of hepatitis B virus (HBV) infection are availa...
BackgroundHepatitis B is a major concern in Africa, especially in HIV-infected patients. Unfortunate...
CITATION: Andersson, M.I. et al. 2015. The HIV/HBV co-infected patient: Time for proactive managemen...
BACKGROUND: Hepatitis B (HBV) and C (HCV) are important causes of morbidity and mortality in people ...
BackgroundFew data on the virological determinants of hepatitis B virus (HBV) infection are availabl...
SummaryObjectivesHuman immunodeficiency virus (HIV) infection in Sub-Saharan Africa is complicated b...
SummaryObjectivesHepatitis B virus (HBV), hepatitis C virus (HCV), and the human immunodeficiency vi...
BACKGROUND: Hepatitis B virus (HBV) infection is endemic in South Africa however, there is limited d...
Background: Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) co-infection in South Afr...
BACKGROUND In West Africa where HIV-1 and HIV-2 co-circulate, the co-infection with hepatitis B v...
BACKGROUND: International Sustainable Development Goals (SDGs) for elimination of hepatitis B virus ...
Abstract Background Approximately 8% of HIV-infected individuals are co-infected with hepatitis B vi...
Chronic hepatitis B virus (HBV) infection affects >10% of the general population and is the leading ...
Background: Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV ...
\ud \ud Co-infection with hepatitis B virus (HBV) is highly prevalent in people living with HIV in S...
BACKGROUND: Few data on the virological determinants of hepatitis B virus (HBV) infection are availa...
BackgroundHepatitis B is a major concern in Africa, especially in HIV-infected patients. Unfortunate...
CITATION: Andersson, M.I. et al. 2015. The HIV/HBV co-infected patient: Time for proactive managemen...
BACKGROUND: Hepatitis B (HBV) and C (HCV) are important causes of morbidity and mortality in people ...
BackgroundFew data on the virological determinants of hepatitis B virus (HBV) infection are availabl...
SummaryObjectivesHuman immunodeficiency virus (HIV) infection in Sub-Saharan Africa is complicated b...
SummaryObjectivesHepatitis B virus (HBV), hepatitis C virus (HCV), and the human immunodeficiency vi...
BACKGROUND: Hepatitis B virus (HBV) infection is endemic in South Africa however, there is limited d...
Background: Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) co-infection in South Afr...
BACKGROUND In West Africa where HIV-1 and HIV-2 co-circulate, the co-infection with hepatitis B v...
BACKGROUND: International Sustainable Development Goals (SDGs) for elimination of hepatitis B virus ...